Steroid-refractory Acute Graft-versus-host Disease Clinical Trials

13 clinical trials for Steroid-refractory Acute Graft-versus-host Disease across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation — RECRUITING · PHASE2
• A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD — RECRUITING · NA
• Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease — RECRUITING · PHASE4
• Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy — RECRUITING · PHASE3
• A Randomised, Open label, Multicentre, Phase 3 Trial of First line Treatment with Mesenchymal Stromal Cells MC0518 Versus Best Available Therapy in Adult and Adolescent Subjects with Steroid refractory Acute Graft versus host Disease After Allogeneic Haematopoietic Stem Cell Transplantation (IDUNN Trial) — TERMINATED · PHASE3
• Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host Disease — ACTIVE_NOT_RECRUITING · PHASE2
• Managed Access Programs for INC424, Ruxolitinib — OTHER
• A Phase I/II Trial of VUM02 Injection for Steroid-refractory Acute Graft-versus-host Disease (SR-aGvHD) Treatment — NOT_YET_RECRUITING · PHASE1
• A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002) — TERMINATED · PHASE3
• Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease — COMPLETED · PHASE1
• T-Guard as Treatment for Steroid Refractory Acute GVHD (BMT CTN 1802) — TERMINATED · PHASE3
• Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT) — TERMINATED
• Methoxsalen and Extracorporeal Photopheresis (ECP) for the Treatment of Pediatric Participants With Steroid Refractory Acute Graft Versus Host Disease — TERMINATED · PHASE3

Refine this search